Improved outcome of steroid withdrawal in mycophenolate mofetil-treated primary cadaveric renal transplant recipients

被引：13

作者：

Kupin, W

Venkat, KK

Goggins, M

Douzdjian, V

Escobar, F

Mozes, M

Abouljoud, M

机构：

[1] Henry Ford Hosp, Div Nephrol & Hypertens, Detroit, MI 48322 USA

[2] Henry Ford Hosp, Dept Transplantat Surg, Detroit, MI 48202 USA

来源：

TRANSPLANTATION PROCEEDINGS | 1999年 / 31卷 / 1-2期

关键词：

D O I：

10.1016/S0041-1345(98)01933-2

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1131 / 1132

页数：2

共 7 条

[1]

FRYER JP, 1994, CLIN TRANSPLANT, V8, P224

[2] Steroid withdrawal in mycophenolate mofetil-treated renal allograft recipients [J].

Grinyo, JM ;

GilVernet, S ;

Seron, D ;

Cruzado, JM ;

Moreso, F ;

Fulladosa, X ;

Castelao, AM ;

Torras, J ;

Hooftman, L ;

Alsina, J .

TRANSPLANTATION, 1997, 63 (11) :1688-1690

[3]

HRICIK DE, 1993, J AM SOC NEPHROL, V4, P1300

[4]

HRICIK DE, 1993, KIDNEY INT, V44, pS26

[5]

Keown P, 1996, TRANSPLANTATION, V61, P1029

[6] Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression [J].

Ratcliffe, PJ ;

Dudley, CRK ;

Higgins, RM ;

Firth, JD ;

Smith, B ;

Morris, PJ .

LANCET, 1996, 348 (9028) :643-648

[7] CORTICOSTEROIDS IN KIDNEY-TRANSPLANT RECIPIENTS - SAFETY ISSUES AND TIMING OF DISCONTINUATION [J].

TARANTINO, A ;

MONTAGNINO, G ;

PONTICELLI, C .

DRUG SAFETY, 1995, 13 (03) :145-156

← 1 →